CNOT2 (Ab-101) Antibody

What is the CNOT2 (Ab-101) Antibody and what epitope does it recognize?

CNOT2 (Ab-101) Antibody is a rabbit polyclonal antibody specifically designed to target human CNOT2 protein around the phosphorylation site of serine 101 with the amino acid sequence S-L-S(p)-Q-G. The antibody was developed using a synthesized non-phosphopeptide derived from this region as an immunogen . It recognizes both human and mouse CNOT2 proteins, making it versatile for comparative studies across these species . This antibody is particularly valuable for studying phosphorylation events at the Ser101 position, which has been implicated in osmotic stress response pathways .

What is the biological significance of CNOT2 in cellular processes?

CNOT2 functions as a critical component of the CCR4-NOT complex, which is one of the major cellular mRNA deadenylases linked to various essential cellular processes. These include bulk mRNA degradation, miRNA-mediated repression, translational repression during initiation, and general transcription regulation . CNOT2 is specifically required for maintaining the CCR4-NOT complex's structural integrity .

Research has demonstrated that CNOT2 can repress transcription and potentially connects the CCR4-NOT complex to transcriptional regulation mechanisms, particularly through interaction with the N-Cor repressor complex containing HDAC3, NCOR1, and NCOR2 . Additionally, CNOT2 plays a crucial role in maintaining embryonic stem (ES) cell identity, suggesting its importance in developmental processes and stem cell biology .

How does CNOT2 phosphorylation at Ser101 relate to cellular stress responses?

Phosphorylation of CNOT2 at Ser101 is significantly induced by osmotic stress, with peak phosphorylation occurring approximately 1 hour after stress exposure before gradually decreasing . This phosphorylation event is mediated by the p38MAPK pathway, specifically through MK2 kinase, which directly phosphorylates CNOT2 at Ser101 as demonstrated through in vitro kinase assays .

The phosphorylation is not limited to osmotic stress but also occurs in response to other cellular stresses including anisomycin treatment, UV irradiation, and IL-1 stimulation - all of which activate the p38MAPK pathway . This suggests that CNOT2 phosphorylation at Ser101 serves as a common stress response mechanism activated by various extra- and intracellular stimuli that engage the p38MAPK signaling cascade.

What are the validated applications for CNOT2 (Ab-101) Antibody?

The CNOT2 (Ab-101) Antibody has been validated for several experimental applications, primarily:

• Western Blotting (WB): Recommended dilution ratio of 1:500-1:3000

• Enzyme-Linked Immunosorbent Assay (ELISA): Recommended dilution ratio of 1:2000-1:10000

The antibody was affinity-purified from rabbit antiserum using epitope-specific immunogen chromatography, ensuring high specificity for the target epitope . While these are the manufacturer-validated applications, researchers should consider performing validation in their specific experimental systems before proceeding with critical experiments.

What is the recommended protocol for detecting CNOT2 phosphorylation at Ser101 using this antibody?

For detecting CNOT2 phosphorylation at Ser101, the following optimized immunoblotting protocol is recommended based on published research:

• Cell Treatment: Induce stress response in your cell culture system (common methods include 0.4M sorbitol treatment for osmotic stress, anisomycin treatment, UV irradiation, or IL-1 stimulation)

• Sample Preparation:

  • Harvest cells at appropriate time points (peak phosphorylation occurs around 1 hour post-stress)

  • Prepare cell lysates in buffer containing phosphatase inhibitors to preserve phosphorylation states

  • For immunoprecipitation: Use anti-FLAG antibody if working with FLAG-tagged CNOT2

• Western Blotting:

  • Separate proteins using SDS-PAGE

  • Transfer to PVDF or nitrocellulose membrane

  • Block with appropriate blocking buffer

  • Incubate with CNOT2 (Ab-101) Antibody at 1:1000 dilution overnight at 4°C

  • Wash and incubate with appropriate secondary antibody

  • Develop using standard chemiluminescence methods

• Controls:

  • Include non-treated cells as negative control

  • Consider using CNOT2 S101A mutant as specificity control

  • Include p38MAPK inhibitor-treated samples to confirm pathway dependency

This protocol has been successfully used to demonstrate stress-induced phosphorylation of CNOT2 at Ser101 in multiple experimental contexts.

How can I validate the specificity of the CNOT2 (Ab-101) Antibody in my experimental system?

To validate antibody specificity in your system, implement these methodological approaches:

• Peptide Competition Assay: Pre-incubate the antibody with phosphorylated and non-phosphorylated peptides. As demonstrated in previous research, specific blocking occurs with the phosphorylated peptide but not with unphosphorylated peptides .

• Mutant Expression: Express wild-type CNOT2 alongside S101A mutant constructs. The antibody should detect wild-type CNOT2 but not the S101A mutant when phosphorylation is induced .

• Phosphatase Treatment: Treat half of your samples with lambda phosphatase before immunoblotting. This should abolish detection if the antibody is truly phospho-specific.

• Kinase Inhibition: Treat cells with p38MAPK pathway inhibitors before stress induction. This should reduce or eliminate the signal if the antibody is detecting phosphorylation dependent on this pathway .

• siRNA Knockdown: Reduce endogenous CNOT2 expression through siRNA to confirm the identity of detected bands.

These validation steps ensure that observed signals are specific to phosphorylated CNOT2 at Ser101 rather than cross-reactivity with other phosphoproteins.

What are common issues when using CNOT2 (Ab-101) Antibody for Western blotting and how can they be resolved?

When troubleshooting specifically for phospho-CNOT2 detection, remember that the phosphorylation signal peaks around 1 hour after stress induction and decreases afterward . Timing sample collection appropriately is critical for consistent results.

How do I distinguish between different phosphorylation states of CNOT2?

CNOT2 contains multiple phosphorylation sites, including Ser101, Ser126, and Ser165, which can create complex band patterns on immunoblots . To distinguish between these phosphorylation states:

• Use Site-Specific Phospho-Antibodies: The CNOT2 (Ab-101) Antibody is specific for Ser101 phosphorylation. For comprehensive analysis, consider using additional antibodies targeting other phosphorylation sites or phospho-motif antibodies for MAPK or CDK substrates .

• Employ Mutational Analysis: Express CNOT2 constructs with specific mutations (S101A, S126A, S165A, or combinations) to identify which bands correspond to which phosphorylation events. Previous research has shown that:

  • S101A mutation eliminates bands detected by phospho-CNOT2 S101 antibody

  • S126A mutation eliminates bands detected by phospho-MAPK/CDK substrate antibody

  • Double mutations can help identify interdependencies between phosphorylation sites

• Conduct Phosphatase Treatment: Treat samples with lambda phosphatase to collapse multiple bands into a single unphosphorylated form.

• Perform 2D Gel Electrophoresis: Separate proteins by isoelectric point and molecular weight to resolve different phosphoforms.

Previous research has identified four distinct bands for CNOT2 on immunoblots, with specific patterns of appearance and disappearance in different mutants and treatment conditions , allowing correlation of band patterns with specific phosphorylation events.

How can CNOT2 (Ab-101) Antibody be used to study the relationship between mRNA metabolism and DNA replication stress?

The CCR4-NOT complex, of which CNOT2 is a crucial component, plays significant roles in mRNA metabolism and has been implicated in DNA replication through multiple mechanisms . Researchers can utilize CNOT2 (Ab-101) Antibody to investigate these connections through the following methodological approaches:

• Chromatin Immunoprecipitation (ChIP) Combined with Western Blotting:

  • Perform ChIP to isolate CNOT2-associated chromatin regions

  • Use CNOT2 (Ab-101) Antibody to determine phosphorylation status at replication sites

  • Compare phosphorylation patterns between normal and replication stress conditions

• Dual Immunofluorescence with Replication Stress Markers:

  • Co-stain cells for phosphorylated CNOT2 (using the Ab-101 antibody) and markers of replication stress (γH2AX, RPA32)

  • Quantify colocalization under various conditions (normal, replication stress, transcription inhibition)

• R-loop Analysis:

  • Since CNOT1 depletion affects transcription and leads to R-loop formation , investigate whether CNOT2 phosphorylation status correlates with R-loop accumulation

  • Use DRIP (DNA-RNA Immunoprecipitation) alongside CNOT2 phosphorylation detection

• Cell Cycle Analysis:

  • Synchronize cells at different cell cycle phases

  • Analyze CNOT2 Ser101 phosphorylation patterns through the cell cycle

  • Correlate with markers of S phase progression and replication stress

This approach can provide insights into how post-translational modifications of CNOT2 might regulate the CCR4-NOT complex's functions in coordinating transcription, mRNA processing, and DNA replication.

What experimental design would be appropriate for studying the role of CNOT2 phosphorylation in stress-induced transcriptional responses?

To investigate CNOT2 phosphorylation in stress-induced transcriptional regulation, implement this comprehensive experimental design:

Phase 1: Establish Phosphorylation-Transcription Relationship

• Generate Cellular Models:

  • Wild-type cells

  • CNOT2-depleted cells (siRNA or CRISPR)

  • Cells expressing phospho-mutants (S101A, phosphomimetic S101D/E)

• Apply Stress Conditions:

  • Osmotic stress (0.4M sorbitol)

  • UV irradiation

  • Inflammatory stimuli (IL-1)

  • Include appropriate time points (peak phosphorylation at ~1hr)

• Analyze Transcriptional Changes:

  • Perform RNA-seq to identify differentially expressed genes

  • Use RT-qPCR to validate key target genes

  • Compare transcriptional responses between genetic models

Phase 2: Mechanistic Investigation

• Chromatin Association Analysis:

  • ChIP-seq for CNOT2 under different conditions

  • Compare wild-type vs. phospho-mutant chromatin binding

  • Co-immunoprecipitation to identify phosphorylation-dependent protein interactions

• Deadenylation Activity Assessment:

  • Measure mRNA half-lives using actinomycin D chase

  • Analyze poly(A) tail lengths using PAT assays

  • Compare deadenylation activity between phosphorylated and non-phosphorylated states

• Signaling Pathway Integration:

  • Inhibit p38MAPK pathway at different stages using specific inhibitors

  • Monitor effects on CNOT2 phosphorylation and transcriptional outcomes

  • Perform phosphoproteomics to identify other targets in the pathway

This experimental design follows the response surface methodology principles , allowing systematic exploration of how phosphorylation affects CNOT2 function across multiple stress conditions and genetic backgrounds.

How should researchers interpret band patterns when analyzing CNOT2 phosphorylation by Western blotting?

When analyzing Western blots for CNOT2 phosphorylation, researchers should interpret band patterns based on the following methodological framework:

• Band Identification Based on Previous Research:

  • Four distinct bands (labeled 1-4) have been observed for CNOT2

  • Band 2 and Band 4 contain Ser126 phosphorylation (constitutive, stress-independent)

  • Band 3 and Band 4 contain Ser165 phosphorylation (augmented by stress)

  • CNOT2 S101 phosphorylation appears as specific bands after stress induction

• Quantitative Analysis:

  • Normalize phospho-specific signals to total CNOT2 protein

  • Plot time-course data to observe phosphorylation dynamics (peaks at ~1hr post-stress)

  • Compare band intensity ratios between different conditions

• Mutant Controls Interpretation:

  • S101A mutation: Eliminates phospho-S101-specific bands

  • S126A mutation: Eliminates bands recognized by phospho-MAPK/CDK substrate antibodies

  • Double mutants: Help confirm band identity through pattern changes

• Pathway Inhibition Effects:

  • p38MAPK inhibitors: Should reduce Ser101 phosphorylation

  • MK2 inhibitors: Should reduce Ser101 phosphorylation

  • CDK inhibitors: May affect Ser126 phosphorylation

This systematic approach allows researchers to accurately identify which bands represent which phosphorylation states, facilitating correct interpretation of experimental results.

What statistical approaches are recommended for analyzing experimental data involving CNOT2 phosphorylation in response to various stressors?

For rigorous statistical analysis of CNOT2 phosphorylation data across different experimental conditions, researchers should consider:

• Experimental Design Considerations:

  • Implement full factorial or response surface designs when testing multiple factors

  • Include appropriate replication (minimum n=3 biological replicates)

  • Incorporate time as a factor in stress response experiments

  • Consider blocked designs when experimental units come from different sources

• Quantitative Analysis Methods:

  • For time-course data: Repeated measures ANOVA or mixed-effects models

  • For multiple treatment comparisons: Two-way ANOVA followed by appropriate post-hoc tests

  • For dose-response relationships: Regression analysis or response surface methodology

• Data Visualization:

  Analysis Type	Recommended Visualization
  Time-course	Line graphs with error bars showing phosphorylation vs. time
  Multiple stressors	Heatmaps showing relative phosphorylation across conditions
  Dose-response	Response surface contour plots for multi-factor experiments
  Pathway relationships	Path diagrams with correlation coefficients

• Statistical Software Recommendations:

  • Use R with specialized packages for experimental design analysis

  • Apply appropriate transformations if data violates normality assumptions

  • Consider non-parametric tests when assumptions cannot be met

• Power Analysis:

  • Conduct a priori power analysis to determine appropriate sample sizes

  • Report effect sizes alongside p-values

  • Consider correction for multiple testing when analyzing large datasets

Following these statistical approaches will ensure robust and reproducible analysis of CNOT2 phosphorylation data, aligning with best practices in experimental design and data analysis .

How can researchers integrate CNOT2 phosphorylation data with broader cellular signaling networks?

To integrate CNOT2 phosphorylation data within larger signaling networks, researchers should employ these methodological strategies:

• Multi-omics Integration:

  • Combine phospho-proteomic data with transcriptomics to correlate CNOT2 phosphorylation with gene expression changes

  • Perform RNA-seq following manipulation of CNOT2 phosphorylation status

  • Compare deadenylation patterns with phosphorylation dynamics

• Pathway Analysis:

  • Map CNOT2 phosphorylation within the p38MAPK signaling cascade

  • Identify upstream regulators and downstream effectors

  • Create signaling network models incorporating temporal dynamics

• Protein-Protein Interaction Studies:

  • Perform immunoprecipitation with phospho-specific antibodies to identify phosphorylation-dependent interactors

  • Compare CCR4-NOT complex composition under different phosphorylation states

  • Investigate interactions with transcription and deadenylation machinery

• Systems Biology Approaches:

  • Develop mathematical models of stress response incorporating CNOT2 phosphorylation

  • Use ordinary differential equations to model temporal dynamics

  • Perform sensitivity analysis to identify critical nodes in the network

• Functional Correlation Analysis:

  • Create correlation matrices between CNOT2 phosphorylation and functional outcomes (mRNA stability, transcription rates, cell survival)

  • Use machine learning approaches to identify patterns and predictive features

  • Implement ANOVA-based response surface methodology to map input-output relationships

This integrated approach allows researchers to contextualize CNOT2 phosphorylation within the broader cellular response to stress and understand its functional significance in coordinating transcriptional and post-transcriptional processes.

What are the potential applications of CNOT2 (Ab-101) Antibody in studying the role of CCR4-NOT complex in disease models?

The CCR4-NOT complex, including CNOT2, has been implicated in various disease processes through its central role in mRNA metabolism and transcriptional regulation. Researchers can utilize CNOT2 (Ab-101) Antibody to investigate disease mechanisms through these methodological approaches:

• Cancer Research Applications:

  • Monitor CNOT2 phosphorylation status in cancer cell lines vs. normal cells

  • Correlate phosphorylation with cell cycle dysregulation, particularly at the G1/S transition, relevant to cancer progression

  • Investigate how stress-induced CNOT2 phosphorylation affects survival of cancer cells under therapy

• Neurodegenerative Disease Models:

  • Examine CNOT2 phosphorylation in cellular models of stress granule formation

  • Investigate relationships between RNA metabolism dysregulation and neurodegeneration

  • Study potential correlations between cellular stress responses and disease progression

• Inflammation and Immune Response:

  • Since CNOT2 phosphorylation is induced by IL-1 stimulation , explore its role in inflammatory signaling cascades

  • Examine CNOT2 phosphorylation in immune cells during activation and differentiation

  • Correlate with expression of inflammatory cytokines and immune response genes

• Cardiovascular Research:

  • Investigate CNOT2 phosphorylation in cardiac cells under hypoxic stress

  • Explore potential connections to gene therapy approaches in congestive heart failure models

  • Study mRNA stability regulation during cardiac remodeling processes

These applications leverage the specificity of the CNOT2 (Ab-101) Antibody to explore disease-relevant signaling pathways and potential therapeutic targets.

How might advanced microscopy techniques be combined with CNOT2 (Ab-101) Antibody for dynamic cellular studies?

To study CNOT2 phosphorylation dynamics at the single-cell level, researchers can combine the CNOT2 (Ab-101) Antibody with these advanced imaging approaches:

• Live-Cell Imaging with Proximity Ligation Assay (PLA):

  • Combine CNOT2 (Ab-101) Antibody with antibodies against other CCR4-NOT components

  • Visualize phosphorylation-dependent complex assembly in real-time

  • Track subcellular localization changes following stress induction

• Super-Resolution Microscopy:

  • Perform STORM or PALM imaging using fluorophore-conjugated CNOT2 (Ab-101) Antibody

  • Achieve nanoscale resolution of CNOT2 phosphorylation in relation to nuclear and cytoplasmic structures

  • Co-localize with mRNA processing bodies and stress granules

• FRET-Based Biosensors:

  • Develop FRET biosensors incorporating phospho-specific antibody fragments

  • Monitor CNOT2 phosphorylation dynamically in living cells

  • Correlate with cellular stress responses in real-time

• Correlative Light and Electron Microscopy (CLEM):

  • Combine fluorescence microscopy using CNOT2 (Ab-101) Antibody with electron microscopy

  • Achieve ultrastructural context for phosphorylation events

  • Examine association with specific cellular compartments at high resolution

• Mass Spectrometry Imaging:

  • Combine immunofluorescence with mass spectrometry imaging

  • Map spatial distribution of CNOT2 phosphorylation across tissues

  • Correlate with metabolic and signaling profiles

These advanced imaging approaches enable researchers to move beyond traditional biochemical methods to understand the spatial and temporal dynamics of CNOT2 phosphorylation in cellular contexts.

What resources are available for researchers studying CNOT2 and the CCR4-NOT complex?

These resources provide researchers with the necessary tools to conduct comprehensive studies on CNOT2 phosphorylation and its functional consequences in various cellular contexts.

What experimental design principles should be applied when studying phosphorylation-dependent functions of CNOT2?

When designing experiments to study phosphorylation-dependent functions of CNOT2, researchers should implement these methodological principles:

• Systematic Factor Exploration:

  • Apply response surface methodology principles to explore interactions between factors

  • Consider factorial designs when studying multiple variables affecting CNOT2 phosphorylation

  • Include appropriate controls for each experimental variable

• Genetic Complementation Strategy:

  • Deplete endogenous CNOT2

  • Rescue with wild-type or phospho-mutant variants

  • Compare functional outcomes to isolate phosphorylation-specific effects

• Temporal Dynamics Consideration:

  • Implement repeated measures designs for time-course experiments

  • Include appropriate sampling points based on known phosphorylation kinetics (peak at ~1hr)

  • Consider crossover designs when comparing multiple treatment conditions

• Pathway Validation Approach:

  • Use specific inhibitors to validate signaling pathways

  • Include genetic approaches (dominant negative constructs, CRISPR interference)

  • Implement inducible systems for temporal control

• Multi-level Analysis Framework:

  • Connect molecular events (phosphorylation) to cellular processes (transcription, mRNA decay)

  • Link to physiological outcomes (stress response, cell cycle progression)

  • Consider blocked designs when experimental units have inherent variability